PIYUSH PATEL: Open Payments
NPI 1629011283 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$615 in 40 payments from 14 companies in 2025. Trend: 2023 $1,161 · 2024 $644 · 2025 $615
Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 13 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $48 |
| ABBVIE INC. | 3 | $46 |
| Lilly USA, LLC | 3 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Exact Sciences Corporation | 2 | $36 |
| ACADIA Pharmaceuticals Inc | 2 | $29 |
| SCPHARMACEUTICALS INC. | 1 | $28 |
Products named: IBSRELA, JARDIANCE, REXULTI, Kerendia, BREZTRI, The Cologuard Plus Collection Kit, VRAYLAR, MOUNJARO.
Industry payments across GA — which companies pay providers there.
